Peripheral Artery Occlusive Disease (PAOD) Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 183 pages | ID: P8F46D96DC0EN
VPAResearch

Abstracts

Peripheral Artery Occlusive Disease (PAOD) ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Peripheral Artery Occlusive Disease (PAOD) disease clinical trials. The research work analyzes the ongoing Peripheral Artery Occlusive Disease (PAOD) clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Peripheral Artery Occlusive Disease (PAOD) treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Peripheral Artery Occlusive Disease (PAOD) clinical trials.

Scope of the Report-

• Ongoing Peripheral Artery Occlusive Disease (PAOD) clinical trials across regions
• Trial information by Phase and Subjects recruited
• Trial information by status, type, sponsor type
• Drugs used for treatment of Peripheral Artery Occlusive Disease (PAOD)
• Both observational and interventional trials analyzed
• Leading companies and universities participating in Peripheral Artery Occlusive Disease (PAOD) clinical trials

Reasons to Buy

• Track competition and design competitive advantages
• Identify right partners to associate with for further research
• Evaluate potential opportunities available in further clinical trials of the disease
• Formulate business development strategies through success rates of clinical trials
• Identify quick markets for recruiting subjects based on trials count by each market

Contents

1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Peripheral Artery Occlusive Disease (PAOD) Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Peripheral Artery Occlusive Disease (PAOD) Trials by Phase
3.2 Ongoing Peripheral Artery Occlusive Disease (PAOD) Trials by Type
3.3 Ongoing Peripheral Artery Occlusive Disease (PAOD) Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Peripheral Artery Occlusive Disease (PAOD) Trials
4.2 Top 10 Countries conducting Peripheral Artery Occlusive Disease (PAOD) Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Peripheral Artery Occlusive Disease (PAOD) Trials by Sponsor Type
5.2 Peripheral Artery Occlusive Disease (PAOD) Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Peripheral Artery Occlusive Disease (PAOD) Trials by year
6.2 Subjects Recruited for Peripheral Artery Occlusive Disease (PAOD) Trials by Phase
6.3 Subjects Recruited for Peripheral Artery Occlusive Disease (PAOD) Trials by Trial Type
6.4 Subjects Recruited for Peripheral Artery Occlusive Disease (PAOD) Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Peripheral Artery Occlusive Disease (PAOD) Trials- Phase
7.2 Ongoing Peripheral Artery Occlusive Disease (PAOD) Trials- Phase
7.3 Ongoing Peripheral Artery Occlusive Disease (PAOD) Trials- Phase
7.4 Ongoing Peripheral Artery Occlusive Disease (PAOD) Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List Of Figures

LIST OF FIGURES

Figure 1: Peripheral Artery Occlusive Disease (PAOD)- Clinical Trials by Country
Figure 2: Peripheral Artery Occlusive Disease (PAOD)- Clinical Trials by Phase of Development, 2018
Figure 3: Peripheral Artery Occlusive Disease (PAOD)- Clinical Trials by Status, 2018
Figure 4: Peripheral Artery Occlusive Disease (PAOD)- Clinical Trials by Type, 2018
Figure 5: Peripheral Artery Occlusive Disease (PAOD)- Clinical Trials Split by Region, 2000-2018
Figure 6: Peripheral Artery Occlusive Disease (PAOD)- Clinical Trials by Type of Economy, 2018
Figure 7: Peripheral Artery Occlusive Disease (PAOD)- Enrolment by Phase, 2018
Figure 8: Peripheral Artery Occlusive Disease (PAOD)- Enrolment by Trial Type, 2018
Figure 9: Peripheral Artery Occlusive Disease (PAOD)- Enrolment by Recruitment Status, 2018
Figure 10: Peripheral Artery Occlusive Disease (PAOD)- Clinical Trials by Sponsor Type, 2018
Figure 11: Peripheral Artery Occlusive Disease (PAOD)- Enrolment by Type of Sponsors
Figure 12: Peripheral Artery Occlusive Disease (PAOD)- Enrolment by Leading Sponsors

List Of Tables

LIST OF TABLES

Table 1: Peripheral Artery Occlusive Disease (PAOD)- Clinical Trials by Sponsor Type, 2018
Table 2: Peripheral Artery Occlusive Disease (PAOD)- Clinical Trials by Economy Type, 2018
Table 3: Peripheral Artery Occlusive Disease (PAOD)- Clinical Trials by Region, 2018
Table 4: Peripheral Artery Occlusive Disease (PAOD)- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Peripheral Artery Occlusive Disease (PAOD)- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Peripheral Artery Occlusive Disease (PAOD)- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Peripheral Artery Occlusive Disease (PAOD)- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Peripheral Artery Occlusive Disease (PAOD)- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Peripheral Artery Occlusive Disease (PAOD)- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company